BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36313739)

  • 21. The safety and satisfaction of ovarian tissue cryopreservation in prepubertal and adolescent girls.
    Lotz L; Barbosa PR; Knorr C; Hofbeck L; Hoffmann I; Beckmann MW; Antoniadis S; Dittrich R
    Reprod Biomed Online; 2020 Apr; 40(4):547-554. PubMed ID: 32199797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates.
    Van der Ven H; Liebenthron J; Beckmann M; Toth B; Korell M; Krüssel J; Frambach T; Kupka M; Hohl MK; Winkler-Crepaz K; Seitz S; Dogan A; Griesinger G; Häberlin F; Henes M; Schwab R; Sütterlin M; von Wolff M; Dittrich R;
    Hum Reprod; 2016 Sep; 31(9):2031-41. PubMed ID: 27378768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrence.
    Kristensen SG; Giorgione V; Humaidan P; Alsbjerg B; Bjørn AB; Ernst E; Andersen CY
    Fertil Steril; 2017 May; 107(5):1206-1213. PubMed ID: 28433369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort.
    Gellert SE; Pors SE; Kristensen SG; Bay-Bjørn AM; Ernst E; Yding Andersen C
    J Assist Reprod Genet; 2018 Apr; 35(4):561-570. PubMed ID: 29497953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility preservation in pediatric female cancer patients.
    Arian SE; Flyckt RL; Herman R; Erfani H; Falcone T
    Fertil Steril; 2018 May; 109(5):941. PubMed ID: 29778393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
    Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
    Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consequences of
    Mamsen LS; Kristensen SG; Pors SE; Bøtkjær JA; Ernst E; Macklon KT; Gook D; Kumar A; Kalra B; Andersen CY
    Front Endocrinol (Lausanne); 2020; 11():593718. PubMed ID: 33519708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.
    Imbert R; Moffa F; Tsepelidis S; Simon P; Delbaere A; Devreker F; Dechene J; Ferster A; Veys I; Fastrez M; Englert Y; Demeestere I
    Hum Reprod; 2014 Sep; 29(9):1931-40. PubMed ID: 24958067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center.
    Dittrich R; Hackl J; Lotz L; Hoffmann I; Beckmann MW
    Fertil Steril; 2015 Feb; 103(2):462-8. PubMed ID: 25487750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgery.
    Oktay K; Bedoschi G; Pacheco F; Turan V; Emirdar V
    Am J Obstet Gynecol; 2016 Jan; 214(1):94.e1-9. PubMed ID: 26601616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time from referral to ovarian tissue cryopreservation in a cohort of Danish women.
    Kristensen SG; Pors SE; Poulsen LC; Andersen ST; Wakimoto Y; Yding Andersen C
    Acta Obstet Gynecol Scand; 2019 May; 98(5):616-624. PubMed ID: 30758835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian tissue cryopreservation: Low usage rates and high live-birth rate after transplantation.
    Hoekman EJ; Louwe LA; Rooijers M; van der Westerlaken LAJ; Klijn NF; Pilgram GSK; de Kroon CD; Hilders CGJM
    Acta Obstet Gynecol Scand; 2020 Feb; 99(2):213-221. PubMed ID: 31538662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryopreservation of ovarian tissue as fertility preservation in young women with multiple sclerosis before stem cell transplantation.
    Colmorn LB; Kristensen SG; Larsen EC; Macklon KT
    Mult Scler Relat Disord; 2023 Jun; 74():104716. PubMed ID: 37087965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryopreservation of ovarian tissue in breast cancer patients: 10 years of experience.
    Fabbri R; Vicenti R; Magnani V; Pasquinelli G; Macciocca M; Parazza I; Paradisi R; Battaglia C; Venturoli S
    Future Oncol; 2012 Dec; 8(12):1613-9. PubMed ID: 23231523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
    Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
    Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal response in patients transplanted with cryopreserved ovarian tissue is independent of whether freezing was performed in childhood or adulthood.
    Hornshøj VG; Dueholm M; Mamsen LS; Ernst E; Andersen CY
    J Assist Reprod Genet; 2021 Nov; 38(11):3039-3045. PubMed ID: 34617199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients.
    Dolmans MM; Iwahara Y; Donnez J; Soares M; Vaerman JL; Amorim CA; Poirel H
    Hum Reprod; 2016 Oct; 31(10):2292-302. PubMed ID: 27591237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
    Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
    Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience, and gynaecological and reproductive health follow-up of young adult women who have undergone ovarian tissue cryopreservation.
    Leflon M; Rives-Feraille A; Letailleur M; Petrovic CH; Martin B; Marpeau L; Jardin F; Aziz M; Stamatoulas-Bastard A; Dumont L; Rondanino C; Rives N
    Reprod Biomed Online; 2022 Nov; 45(5):913-922. PubMed ID: 36085268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.